P. Céballos

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009–2013)

K. Klouche, O. Jonquet, N. Fegueux, 2016, Bone Marrow Transplantation.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program.

P. Chevallier, I. Yakoub-Agha, A. Thiébaut, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

M. De Carvalho Bittencourt, L. Reppel, D. Bensoussan, 2017, Journal of Hematology & Oncology.

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers

P. Chevallier, I. Yakoub-Agha, M. Mohty, 2017, Haematologica.

Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high risk acute myeloid leukemia or myelodysplastic syndrome.

P. Chevallier, S. Thépot, L. Planche, 2021, Transplantation and cellular therapy.

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

B. Klein, J. Daurès, D. Pouessel, 2006, Bone Marrow Transplantation.

Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

[Intraperitoneal migration of Filshie tubal sterilization clips: an uncommon cause of chronic abdominal pain].

S. Riviére, A. Konaté, S. Chalon, 2002, Gastroenterologie clinique et biologique.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin’s lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

R. Porcher, J. Bourhis, M. Bernard, 2013, Haematologica.

Letermovir for secondary prophylaxis of CMV infection and disease after allogeneic hematopoietic cell transplantation: Results from the French compassionate program.

A. Thiébaut, C. Cordonnier, S. Alain, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

H. Tilly, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Controlled Epstein–Barr virus reactivation after allogeneic transplantation is associated with improved survival

J. Rossi, B. Klein, N. Fegueux, 2014, European journal of haematology.

Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?

J. de Vos, G. Cartron, N. Fegueux, 2018, Current research in translational medicine.

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

J. Moreaux, J. de Vos, J. Veyrune, 2020, Journal of clinical medicine.

Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT

M. Mohty, P. Rohrlich, E. Deconinck, 2016, Haematologica.

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.

R. Herbrecht, J. Dalle, S. Ducastelle-Leprêtre, 2019, Diagnostic microbiology and infectious disease.

In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study

P. Chevallier, D. Blaise, M. Béné, 2021, Blood advances.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

M. Robin, P. Chevallier, I. Yakoub-Agha, 2020, American journal of hematology.

20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

H. Lanic, P. Chevallier, M. Mohty, 2021, Blood.

On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

M. Robin, P. Chevallier, I. Yakoub-Agha, 2023, Acta Haematologica.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Comparison of Mobilized Peripheral Blood Stem Cells Versus Unmanipulated Bone Marrow Haploidentical Transplantation Using Post-Transplant Cyclophosphamide: A Retrospective Study of SFGM-TC in 176 Patients

I. Yakoub-Agha, L. Mannone, E. Deconinck, 2017 .

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

M. Labopin, D. Blaise, M. Mohty, 2024, Blood cancer journal.

[Cardiac complications following allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)].

I. Yakoub-Agha, I. Ahmad, P. Turlure, 2022, Bulletin du cancer.

Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

P. Chevallier, M. Mohty, T. Cluzeau, 2023, EClinicalMedicine.

Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.

H. Einsele, P. Chevallier, I. Yakoub-Agha, 2015, Blood.